Gelonghui April 25 丨 Kangchen Pharmaceutical (603590)(603590bonuspokeronline.SH) releases 2023 annual reportbonuspokeronlineIn 2023, the company will achieve operating income of 9bonuspokeronline.20 billion yuan, an increase of 6.15% over the same period last yearbonuspokeronline; Net profit attributable to owners of the parent company was 150 million yuan, an increase of 48.24% over the same period last year; net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 127 million yuan, an increase of 42.51% over the same period last year; Basic earnings per share were 0.96 yuan. It is planned to distribute a cash dividend of RMB 3.00 (including tax) to all shareholders for every 10 shares.
